Literature DB >> 24726827

Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia.

Tatsuya Shiraki1, Osamu Iida2, Mitsuyoshi Takahara3, Shin Okamoto2, Ikurou Kitano4, Yoshihiko Tsuji4, Hiroto Terashi5, Masaaki Uematsu2.   

Abstract

OBJECTIVE: The latest guideline points to life expectancy of <2 years as the main determinant in revascularization modality selection (bypass surgery [BSX] or endovascular therapy [EVT]) in patients with critical limb ischemia (CLI). This study examined predictors and a predictive scoring model of 2-year mortality after revascularization.
METHODS: We performed Cox proportional hazards regression analysis of data in a retrospective database, the Bypass and Endovascular therapy Against Critical limb ischemia from Hyogo (BEACH) registry, of 459 consecutive CLI patients who underwent revascularization (396 EVT and 63 BSX cases between January 2007 and December 2011) to determine predictors of 2-year mortality. The predictive performance of the score was assessed with the area under the time-dependent receiver operating characteristic curve.
RESULTS: Of 459 CLI patients (mean age, 72 ± 10 years; 64% male; 49% nonambulatory status, 68% diabetes mellitus, 47% on regular dialysis, and 18% rest pain and 82% tissue loss as treatment indication), 84 died within 2 years after revascularization. In a multivariate model, age >75 years (hazard ratio [HR], 1.77; 95% confidence interval [CI], 1.10-2.85), nonambulatory status (HR, 5.32; 95% CI, 2.96-9.56), regular dialysis (HR, 1.90; 95% CI, 1.10-3.26), and ejection fraction <50% (HR, 2.49; 95% CI, 1.48-4.20) were independent predictors of 2-year mortality. The area under the time-dependent receiver operating characteristic curve for the developed predictive BEACH score was 0.81 (95% CI, 0.76-0.86).
CONCLUSIONS: Predictors of 2-year mortality after EVT or BSX in CLI patients included age >75 years, nonambulatory status, regular dialysis, and ejection fraction <50%. The BEACH score derived from these predictors allows risk stratification of CLI patients undergoing revascularization.
Copyright © 2014 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24726827     DOI: 10.1016/j.jvs.2014.02.059

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Phase Ib Safety, Two-Dose Study of MultiGeneAngio in Patients with Chronic Critical Limb Ischemia.

Authors:  Moshe Y Flugelman; Moshe Halak; Boris Yoffe; Jacob Schneiderman; Chen Rubinstein; Allan-Isaac Bloom; Eran Weinmann; Ilya Goldin; Victor Ginzburg; Olga Mayzler; Aaron Hoffman; Belly Koren; Diana Gershtein; Michal Inbar; Marina Hutoran; Adili Tsaba
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

Review 2.  Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Authors:  Ehrin J Armstrong; Kalkidan Bishu; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

3.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

Review 4.  Current Perspective on Hemodialysis Patients with Peripheral Artery Disease.

Authors:  Shin Okamoto; Osamu Iida; Toshiaki Mano
Journal:  Ann Vasc Dis       Date:  2017-06-25

5.  Coronary Artery Disease in Patients with Critical Limb Ischemia Undergoing Major Amputation or Not.

Authors:  Akio Nishijima; Naoto Yamamoto; Ryuichi Yoshida; Koji Hozawa; Satoshi Yanagibayashi; Megumi Takikawa; Rie Hayasaka; Junko Nishijima; Masahiko Gosho; Haruo Nishijima
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-06-28

6.  Multiple metabolic comorbidities and their consequences among patients with peripheral arterial disease.

Authors:  Young Shin Park; Gi Wook Ryu; Mona Choi
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.752

7.  Maggot debridement therapy for a patient with critical limb ischaemia and severe cardiac dysfunction: possibility of limb salvage.

Authors:  Akio Nishijima; Naoto Yamamoto; Ryuichi Yoshida; Koji Hozawa; Satoshi Yanagibayashi; Megumi Takikawa; Rie Hayasaka; Junko Nishijima; Tadasu Okada; Mitsuru Sekido
Journal:  Case Reports Plast Surg Hand Surg       Date:  2017-05-16

8.  Infrainguinal bypass under triple nerve block in patients with severely compromised left ventricular ejection fraction and chronic limb-threatening ischemia.

Authors:  Muzafar Mamatkulov; Nikolai Naumov; Pavel Kurianov; Alexey Yaroslavsky; Alexey Sergeev; Anastasia Voronova
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.